avapro has been researched along with Dilatation, Pathologic in 3 studies
Irbesartan: A spiro compound, biphenyl and tetrazole derivative that acts as an angiotensin II type 1 receptor antagonist. It is used in the management of HYPERTENSION, and in the treatment of kidney disease.
irbesartan : A biphenylyltetrazole that is an angiotensin II receptor antagonist used mainly for the treatment of hypertension.
Dilatation, Pathologic: The condition of an anatomical structure's being dilated beyond normal dimensions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Sawada, H | 1 |
| Ohno-Urabe, S | 1 |
| Ye, D | 1 |
| Franklin, MK | 1 |
| Moorleghen, JJ | 1 |
| Howatt, DA | 1 |
| Mullick, AE | 1 |
| Daugherty, A | 1 |
| Lu, HS | 1 |
| Mullen, MJ | 1 |
| Flather, MD | 1 |
| Jin, XY | 1 |
| Newman, WG | 1 |
| Erdem, G | 1 |
| Gaze, D | 1 |
| Valencia, O | 1 |
| Banya, W | 1 |
| Foley, CE | 1 |
| Child, A | 1 |
| Parkhomenko, AN | 1 |
| Irkin, OI | 1 |
| Kushnir, SP | 1 |
| Bryl, ZV | 1 |
| Soliarik, O | 1 |
| Shkliar, LV | 1 |
2 trials available for avapro and Dilatation, Pathologic
| Article | Year |
|---|---|
A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Aorta; Aortic Aneurysm; Biphenyl Compoun | 2013 |
Additional effects of irbesartan when compared to captopril in the prevention of post-infarction left ventricular dilatation.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Capt | 2002 |
1 other study available for avapro and Dilatation, Pathologic
| Article | Year |
|---|---|
Inhibition of the Renin-Angiotensin System Fails to Suppress β-Aminopropionitrile-Induced Thoracic Aortopathy in Mice-Brief Report.
Topics: Aminopropionitrile; Angiotensin II; Angiotensinogen; Animals; Aortic Aneurysm, Thoracic; Aortic Rupt | 2022 |